Kriti Nutrients Ltd. Q1 FY27 Unaudited Results Approved
Kriti Nutrients Limited's Board approved unaudited standalone and consolidated financial results for Q1 FY27. Revenue from operations was ₹24,707.76 lakhs. Net profit after tax was ₹905.66 lakhs (standalone) and ₹891.85 lakhs (consolidated). EPS stood at ₹1.81 (standalone basic) and ₹1.78 (consolidated basic).
The approval of quarterly financial results is a standard disclosure for listed companies and directly impacts investors' understanding of the company's performance. The data provided is material for investment decisions.
The announcement reports the unaudited financial results for the quarter. While the results are presented, there is no significant positive or negative news, such as substantial profit growth or decline, or significant new business developments. The tone is factual and routine.
Kriti Nutrients Limited announced the outcome of its Board Meeting held on August 11, 2026. The board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also took on record the Limited Review Report from its statutory auditors for these results.
The financial results for the quarter ended June 30, 2026, show standalone revenue from operations of ₹24,707.76 lakhs and consolidated revenue from operations of ₹24,707.76 lakhs. Total revenue for the quarter stood at ₹24,875.11 lakhs on a standalone basis and ₹24,875.11 lakhs on a consolidated basis.
Expenses for the quarter included cost of materials consumed at ₹20,107.84 lakhs (standalone and consolidated), and purchases of stock-in-trade at ₹1,819.56 lakhs (standalone and consolidated). Employee benefits expense was ₹414.25 lakhs, and finance costs were ₹23.81 lakhs.
Profit before tax for the quarter was ₹1,172.53 lakhs on a standalone basis and ₹1,172.53 lakhs on a consolidated basis. After accounting for total tax expenses of ₹266.87 lakhs (standalone and consolidated), the net profit after tax for the quarter stood at ₹905.66 lakhs (standalone) and ₹891.85 lakhs (consolidated). Other comprehensive income for the period was ₹907.40 lakhs (standalone) and ₹893.51 lakhs (consolidated).
Earnings per share (EPS) for the quarter ended June 30, 2026, were ₹1.81 on a basic and diluted basis for standalone operations, and ₹1.78 on a basic and diluted basis for consolidated operations.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.